Alessandra Dall'acqua

Aviano, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 17 publications

Quality of radiation shapes survival, invasiveness, and migration in ovarian cancer cell lines with different molecular profiles and varying alpha/beta ratios: an in vitro study on behalf of the Multicenter Italian Trials in Ovarian Cancer (MITO) group.

Quality of radiation shapes survival, invasiveness, and migration in ovarian cancer cell lines with different molecular profiles and varying alpha/beta ratios: an in vitro study on behalf of the Multicenter Italian Trials in Ovarian Cancer (MITO) group.

Journal: International journal of radiation biology

Published: August 06, 2025

Cyclin-dependent protein kinases and cell cycle regulation in biology and disease.

Cyclin-dependent protein kinases and cell cycle regulation in biology and disease.

Journal: Signal transduction and targeted therapy

Published: June 20, 2024

A comprehensive luminal breast cancer patient-derived xenografts (PDX) library to capture tumor heterogeneity and explore the mechanisms of resistance to CDK4/6 inhibitors.

A comprehensive luminal breast cancer patient-derived xenografts (PDX) library to capture tumor heterogeneity and explore the mechanisms of resistance to CDK4/6 inhibitors.

Journal: The Journal of pathology

Published: May 08, 2024

Loss of the extracellular matrix glycoprotein EMILIN1 accelerates Δ16HER2-driven breast cancer initiation in mice.

Loss of the extracellular matrix glycoprotein EMILIN1 accelerates Δ16HER2-driven breast cancer initiation in mice.

Journal: NPJ breast cancer

Published: July 10, 2023

Loss of CDKN1B induces an age-related clonal hematopoietic disorder via Notch2 activity dysregulation.

Loss of CDKN1B induces an age-related clonal hematopoietic disorder via Notch2 activity dysregulation.

Journal: Cancer communications (London, England)

Published: December 12, 2022

CDK4/6 Inhibitors in Combination Therapies: Better in Company Than Alone: A Mini Review.

CDK4/6 Inhibitors in Combination Therapies: Better in Company Than Alone: A Mini Review.

Journal: Frontiers in oncology

Published: March 07, 2022

p27kip1 expression and phosphorylation dictate Palbociclib sensitivity in KRAS-mutated colorectal cancer.

p27kip1 expression and phosphorylation dictate Palbociclib sensitivity in KRAS-mutated colorectal cancer.

Journal: Cell death & disease

Published: July 20, 2021

Inhibition of CDK4/6 as Therapeutic Approach for Ovarian Cancer Patients: Current Evidences and Future Perspectives.

Inhibition of CDK4/6 as Therapeutic Approach for Ovarian Cancer Patients: Current Evidences and Future Perspectives.

Journal: Cancers

Published: April 28, 2021

CDKN1B mutation and copy number variation are associated with tumor aggressiveness in luminal breast cancer.

CDKN1B mutation and copy number variation are associated with tumor aggressiveness in luminal breast cancer.

Journal: The Journal of pathology

Published: May 22, 2020

Serum- and glucocorticoid- inducible kinase 2, SGK2, is a novel autophagy regulator and modulates platinum drugs response in cancer cells.

Serum- and glucocorticoid- inducible kinase 2, SGK2, is a novel autophagy regulator and modulates platinum drugs response in cancer cells.

Journal: Oncogene

Published: December 30, 2019

Splicing factor proline- and glutamine-rich (SFPQ) protein regulates platinum response in ovarian cancer-modulating SRSF2 activity.

Splicing factor proline- and glutamine-rich (SFPQ) protein regulates platinum response in ovarian cancer-modulating SRSF2 activity.

Journal: Oncogene

Published: September 27, 2019

USP1 links platinum resistance to cancer cell dissemination by regulating Snail stability.

USP1 links platinum resistance to cancer cell dissemination by regulating Snail stability.

Journal: Science advances

Published: September 05, 2018

Showing 1-12 of 17

Last Updated: 09/26/2026